查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945504

2026年全球哺乳动物细胞库市场报告

Mammalian Cell Banking Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，哺乳动物细胞库市场发展迅速，预计将从2025年的31.4亿美元成长到2026年的35亿美元，复合年增长率达11.3%。过去几年的成长要素包括单株抗体开发、疫苗生产扩张、监管品质要求、学术研究的扩展以及生物製药的商业化。

预计未来几年哺乳动物细胞库市场将快速成长，到2030年市场规模将达到53.1亿美元，复合年增长率（CAGR）为11.0%。预测期内的成长要素包括基因治疗的进步、个人化医疗的扩展、生物相似药的开发、细胞疗法研发管线的拓展以及对长期细胞可追溯性的需求。预测期内的关键趋势包括细胞株保存的标准化、生物製药研发管线的扩展、符合现行药品生产品质管理规范（CGMP）的细胞库的扩张、对遗传稳定性的日益重视以及外包给专业机构的增加。

对细胞疗法日益增长的需求预计将显着推动哺乳动物细胞库市场的扩张。细胞疗法是一种先进治疗方法，它利用活细胞（通常经过改造或基因工程）来修復、替换或再生受损的组织和器官，从而为多种疾病提供标靶治疗。慢性病和罕见疾病的增加促使人们需要更有效、更精准的治疗方法。哺乳动物细胞库在支持这些疗法方面发挥着至关重要的作用，它们提供稳定、高品质的细胞来源，并确保再生医学研发和生产的安全性、扩充性和可靠性。例如，美国基因与细胞治疗方法学会 (ASGCT) 在 2024 年 4 月报告称，处于临床开发平臺的治疗方法数量正在增加，尤其是 I 期临床试验的增长率高达 11%，为 2022 年底以来的最高水平。对细胞疗法需求的激增正在推动哺乳动物细胞库市场的成长。

哺乳动物细胞库市场的企业正透过开发创新的稳定细胞株系统来推动该领域的发展，这些系统能够提高细胞株的生产力，确保长期的遗传稳定性，并简化生物製药生产流程。稳定细胞株系统是指经过基因工程改造的哺乳动物细胞，它们能够在保持高度遗传稳定性的同时，持续数代生产特定的蛋白质或治疗分子。例如，总部位于中国的生物製药公司药明生物于2024年8月推出了WuXia293稳定细胞株平台。该平台基于HEK293细胞，专为开发和生产具有挑战性的生物分子而设计。凭藉专有的细胞株开发技术，该平台能够确保稳定的表达、一致的品质和可扩展的生产，克服了传统CHO细胞系统常见的产量低和品质下降等问题。 WuXia293稳定细胞系平台能够提供更高的蛋白质产量、更接近人源的糖基化修饰以及更有效率的生产，适用于临床和商业应用。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球哺乳动物细胞库市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 细胞株保存的标准化
    • 生物製药研发管线的成长
    • 扩大符合CGMP标准的细胞库
    • 日益关注遗传稳定性
    • 增加外包给专业设施

第五章 终端用户产业市场分析

  • 生物製药公司
  • 学术研究机构
  • 合约研究机构
  • 疫苗生产商
  • 基因治疗开发公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球哺乳动物细胞库市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球哺乳动物细胞库市场规模、对比及成长率分析
  • 全球哺乳动物细胞库市场表现：规模与成长，2020-2025年
  • 全球哺乳动物细胞库市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 主细胞库，工作细胞库
  • 按细胞类型
  • 中国仓鼠卵巢细胞（CHO）、幼仓鼠肾细胞（BHK）、非分泌型0细胞（NS0）、YB2/0和P2/0、人类胚胎肾293细胞（HEK293）及其衍生、亨丽埃塔·拉克斯细胞（HELA）
  • 依储存类型
  • 液态氮、速冻机、快速冷冻
  • 透过使用
  • 药物研发、疫苗生产、基因治疗、单株抗体生产
  • 最终用户
  • 学术研究机构、生物製药公司、受託研究机构（CRO）
  • 按类型细分：主细胞库
  • 重组细胞株、融合瘤细胞株、原代细胞株、基因工程细胞株、病毒载体生产细胞株
  • 按类型细分：工作细胞库
  • 符合现行良好生产规范 (CGMP) 的细胞库、研究级细胞库、临床试验细胞库、商业生产细胞库和稳定性测试细胞库

第十章 区域与国家分析

  • 全球哺乳动物细胞库市场：区域分析、预测及成长，2020-2025年、2025-2030年预测、2035年预测
  • 全球哺乳动物细胞库市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 哺乳动物细胞库市场：竞争格局及市场占有率（2024年）
  • 哺乳动物细胞库市场：公司估值矩阵
  • 哺乳动物细胞库市场：公司概况
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Eurofins Scientific SE
    • Charles River Laboratories International Inc.

第37章：其他领先和创新企业

  • Catalent Inc., Sartorius Stedim Biotech SA, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics SA, Abzena plc, 53Biologics, Cellistic

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年哺乳动物细胞库市场：提供新机会的国家
  • 2030年哺乳动物细胞库市场：新兴细分市场机会
  • 2030年哺乳动物细胞库市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MMCBE01_G26Q1

Mammalian cell banking is the organized procedure of producing, preserving, and storing well-characterized mammalian cell stocks under strict conditions, typically at very low temperatures, to ensure their long-term survival, genetic consistency, and functional performance. This method maintains the cells' uniformity, prevents contamination, and preserves their original traits over time, providing a reliable and standardized resource for future use.

The primary types of products in mammalian cell banking are master cell bank and working cell bank. A master cell bank (MCB) is a carefully prepared and extensively characterized collection of cells stored in multiple vials under controlled cryogenic conditions. It includes various cell types such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), non-secreting 0 (NS0), YB2/0 and P2/0, human embryonic kidney 293 (HEK293) and derivatives, and HeLa cells. Storage methods include liquid nitrogen, controlled-rate freezing, and flash freezing. Master cell banks are used in drug development, vaccine production, gene therapy, and monoclonal antibody production, serving end users such as academic and research laboratories, biopharmaceutical companies, and contract research organizations (CROs).

Tariffs have influenced the mammalian cell banking market by raising costs for cryogenic equipment, storage systems, and specialized consumables sourced internationally. Biopharmaceutical production hubs in North America, Europe, and Asia-Pacific are most affected, particularly master and working cell bank segments. On the positive side, tariffs are driving domestic manufacturing investments, improved supply chain security, and regional cell banking infrastructure development.

The mammalian cell banking market research report is one of a series of new reports from The Business Research Company that provides mammalian cell banking market statistics, including mammalian cell banking industry global market size, regional shares, competitors with a mammalian cell banking market share, detailed mammalian cell banking market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian cell banking industry. This mammalian cell banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammalian cell banking market size has grown rapidly in recent years. It will grow from $3.14 billion in 2025 to $3.5 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to monoclonal antibody development, vaccine manufacturing growth, regulatory quality requirements, academic research expansion, biologics commercialization.

The mammalian cell banking market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to gene therapy advancements, personalized medicine growth, biosimilar development, cell-based therapy pipelines, long-term cell traceability needs. Major trends in the forecast period include standardization of cell line preservation, growth of biopharmaceutical pipelines, expansion of CGMP-compliant cell banks, increased focus on genetic stability, rising outsourcing to specialized facilities.

The growing demand for cell-based therapies is expected to significantly drive the expansion of the mammalian cell banking market. Cell-based therapies involve advanced treatments using living, often modified or engineered, cells to repair, replace, or regenerate damaged tissues and organs, offering targeted solutions for various diseases. As chronic and rare diseases become more prevalent, there is an increasing need for more effective and precise treatments. Mammalian cell banking plays a key role in supporting these therapies by providing a consistent, high-quality cell source, ensuring safety, scalability, and reliability in the development and production of regenerative treatments. For example, the American Society of Gene and Cell Therapy reported in April 2024 that the number of therapies in clinical pipelines has grown, with Phase I trials showing the strongest growth of 11% since late 2022. This surge in demand for cell-based therapies is therefore fueling the growth of the mammalian cell banking market.

Companies in the mammalian cell banking market are advancing the field by developing innovative stable cell line systems that improve cell line productivity, ensure long-term genetic stability, and streamline biopharmaceutical manufacturing. Stable cell line systems are engineered mammalian cells that can consistently produce specific proteins or therapeutic molecules across generations with high genetic stability. For example, WuXi Biologics, a biopharmaceutical company based in China, introduced the WuXia293 Stable platform in August 2024. This HEK293-based stable cell line system is designed for the development and production of challenging biologic molecules. By using proprietary cell line development technology, the platform ensures stable expression, consistent quality, and scalable production, overcoming challenges typically seen with traditional CHO cell systems, such as low yields and compromised quality. The WuXia293 Stable platform provides higher protein yields, better human-like glycosylation, and more efficient production for clinical and commercial use.

In April 2025, Sartorius, a Germany-based life sciences technology provider, formed a strategic CDMO collaboration with Mabion S.A. to support comprehensive biopharmaceutical development using mammalian cell systems. This partnership enables Sartorius to enhance its capabilities in mammalian cell banking by combining advanced cell line development, upstream process optimization, and proprietary cell culture media with Mabion's GMP-compliant process development, scale-up, and large-scale biologics manufacturing. Mabion is a Poland-based biopharmaceutical CDMO focused on mammalian cell culture-based protein production and GMP manufacturing of both drug substances and drug products.

Major companies operating in the mammalian cell banking market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Eurofins Scientific SE, Charles River Laboratories International Inc., Catalent Inc., Sartorius Stedim Biotech S A, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics S A, Abzena plc, 53Biologics, Cellistic, GBI Biomanufacturing, ABL Inc, OmniaBio, uBriGene Biosciences

North America was the largest region in the mammalian cell banking market in 2025. The regions covered in the mammalian cell banking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The mammalian cell banking market consists of sales of cryopreservation media, cell culture reagents, storage vials, cryogenic storage equipment, and quality control kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Banking Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mammalian cell banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell banking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Master Cell Bank; Working Cell Bank
  • 2) By Cell Type: Chinese Hamster Ovary Mammalian Cell Banking (CHO); Baby Hamster Kidney (BHK); Non-Secreting 0 (NS0); YB2/0 And P2/0; Human Embryonic Kidney 293 (HEK293) And Derivatives; Henrietta Lacks (HELA)
  • 3) By Storage Type: Liquid Nitrogen; Controlled Rate Freezer; Flash Freezing
  • 4) By Application: Drug Development; Vaccine Production; Gene Therapy; Monoclonal Antibody Production
  • 5) By End User: Academic And Research Laboratories; Biopharmaceutical Companies; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Master Cell Bank: Recombinant Cell Lines; Hybridoma Cell Lines; Primary Cell Lines; Genetically Engineered Cell Lines; Viral Vector Producing Cell Lines
  • 2) By Working Cell Bank: Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks; Research-Grade Cell Banks; Clinical Trial Cell Banks; Commercial Production Cell Banks; Stability Testing Cell Banks
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; Eurofins Scientific SE; Charles River Laboratories International Inc.; Catalent Inc.; Sartorius Stedim Biotech S A; Samsung Biologics Co Ltd; CMIC Holdings Co Ltd; WuXi Biologics Inc.; Evotec SE; AGC Biologics Inc.; GenScript ProBio Co Ltd; Syngene International Limited; KBI Biopharma Inc.; Rentschler Biopharma SE; Polpharma Biologics S A; Abzena plc; 53Biologics; Cellistic; GBI Biomanufacturing; ABL Inc; OmniaBio; uBriGene Biosciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Mammalian Cell Banking Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Mammalian Cell Banking Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Mammalian Cell Banking Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Mammalian Cell Banking Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Standardization Of Cell Line Preservation
    • 4.2.2 Growth Of Biopharmaceutical Pipelines
    • 4.2.3 Expansion Of Cgmp-Compliant Cell Banks
    • 4.2.4 Increased Focus On Genetic Stability
    • 4.2.5 Rising Outsourcing To Specialized Facilities

5. Mammalian Cell Banking Market Analysis Of End Use Industries

  • 5.1 Biopharmaceutical Companies
  • 5.2 Academic And Research Laboratories
  • 5.3 Contract Research Organizations
  • 5.4 Vaccine Manufacturers
  • 5.5 Gene Therapy Developers

6. Mammalian Cell Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Mammalian Cell Banking Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Mammalian Cell Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Mammalian Cell Banking Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Mammalian Cell Banking Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Mammalian Cell Banking Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Mammalian Cell Banking Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Mammalian Cell Banking Market Segmentation

  • 9.1. Global Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Master Cell Bank, Working Cell Bank
  • 9.2. Global Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chinese Hamster Ovary Mammalian Cell Banking (CHO), Baby Hamster Kidney (BHK), Non-Secreting 0 (NS0), YB2/0 And P2/0, Human Embryonic Kidney 293 (HEK293) And Derivatives, Henrietta Lacks (HELA)
  • 9.3. Global Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid Nitrogen, Controlled Rate Freezer, Flash Freezing
  • 9.4. Global Mammalian Cell Banking Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Development, Vaccine Production, Gene Therapy, Monoclonal Antibody Production
  • 9.5. Global Mammalian Cell Banking Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Laboratories, Biopharmaceutical Companies, Contract Research Organizations (CROs)
  • 9.6. Global Mammalian Cell Banking Market, Sub-Segmentation Of Master Cell Bank, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Recombinant Cell Lines, Hybridoma Cell Lines, Primary Cell Lines, Genetically Engineered Cell Lines, Viral Vector Producing Cell Lines
  • 9.7. Global Mammalian Cell Banking Market, Sub-Segmentation Of Working Cell Bank, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks, Research-Grade Cell Banks, Clinical Trial Cell Banks, Commercial Production Cell Banks, Stability Testing Cell Banks

10. Mammalian Cell Banking Market Regional And Country Analysis

  • 10.1. Global Mammalian Cell Banking Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Mammalian Cell Banking Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Mammalian Cell Banking Market

  • 11.1. Asia-Pacific Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Mammalian Cell Banking Market

  • 12.1. China Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Mammalian Cell Banking Market

  • 13.1. India Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Mammalian Cell Banking Market

  • 14.1. Japan Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Mammalian Cell Banking Market

  • 15.1. Australia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Mammalian Cell Banking Market

  • 16.1. Indonesia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Mammalian Cell Banking Market

  • 17.1. South Korea Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Mammalian Cell Banking Market

  • 18.1. Taiwan Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Mammalian Cell Banking Market

  • 19.1. South East Asia Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Mammalian Cell Banking Market

  • 20.1. Western Europe Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Mammalian Cell Banking Market

  • 21.1. UK Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Mammalian Cell Banking Market

  • 22.1. Germany Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Mammalian Cell Banking Market

  • 23.1. France Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Mammalian Cell Banking Market

  • 24.1. Italy Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Mammalian Cell Banking Market

  • 25.1. Spain Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Mammalian Cell Banking Market

  • 26.1. Eastern Europe Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Mammalian Cell Banking Market

  • 27.1. Russia Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Mammalian Cell Banking Market

  • 28.1. North America Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Mammalian Cell Banking Market

  • 29.1. USA Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Mammalian Cell Banking Market

  • 30.1. Canada Mammalian Cell Banking Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Mammalian Cell Banking Market

  • 31.1. South America Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Mammalian Cell Banking Market

  • 32.1. Brazil Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Mammalian Cell Banking Market

  • 33.1. Middle East Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Mammalian Cell Banking Market

  • 34.1. Africa Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Mammalian Cell Banking Market, Segmentation By Product Type, Segmentation By Cell Type, Segmentation By Storage Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Mammalian Cell Banking Market Regulatory and Investment Landscape

36. Mammalian Cell Banking Market Competitive Landscape And Company Profiles

  • 36.1. Mammalian Cell Banking Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Mammalian Cell Banking Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Mammalian Cell Banking Market Company Profiles
    • 36.3.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Mammalian Cell Banking Market Other Major And Innovative Companies

  • Catalent Inc., Sartorius Stedim Biotech S A, Samsung Biologics Co Ltd, CMIC Holdings Co Ltd, WuXi Biologics Inc., Evotec SE, AGC Biologics Inc., GenScript ProBio Co Ltd, Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, Polpharma Biologics S A, Abzena plc, 53Biologics, Cellistic

38. Global Mammalian Cell Banking Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Mammalian Cell Banking Market

40. Mammalian Cell Banking Market High Potential Countries, Segments and Strategies

  • 40.1 Mammalian Cell Banking Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Mammalian Cell Banking Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Mammalian Cell Banking Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer